IP Library Assignment 027303/0917
Patent Assignment
Reel/Frame 027303/0917

Nunc Pro Tunc Assignment

Recorded: 2011-11-30 Pages: 2
Assignor
VANTIA LIMITED
Executed: 2011-11-18
Assignee
KALVISTA PHARMACEUTICALS LIMITED
90 HIGH HOLBORN, LONDON, WC1V 6XX, UNITED KINGDOM
Covered Property (1)
Selective Dipeptide Inhibitors of Kallikrein
Patent: 7,649,000 →
Application: 10/506,535 →
Publication: US 2006/0052313
Related Assignments (4)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest Jul 5, 2005
From: EVANS, DAVID MICHAEL
To: FERRING B.V.
Reel/Frame 016929/0148 →
Assignment of Assignor's Interest Feb 17, 2009
From: FERRING BV
To: VANTIA LIMITED
Reel/Frame 022266/0100 →
Corrective Assignment to Correct the Corrective Assignment to Correct the Assingnee's Address Previously Recorded at Reel 022266 Frame 0100. Previously Recorded on Reel 022266 Frame 0100. Assignor(S) Hereby Confirms the Assignment. Mar 10, 2009
From: FERRING BV
To: VANTIA LIMITED
Reel/Frame 022368/0479 →
Assignment of Assignor's Interest Mar 26, 2021
From: XF, LLC (FORMERLY, "ROSENTHAL COLLINS GROUP, LLC")
To: PRIME TRADING, LLC
Reel/Frame 055737/0171 →